Status:
COMPLETED
Reliability of IBP Criteria & Activity Scores in Patients With AxSpA
Lead Sponsor:
Zagazig University
Conditions:
Axial Spondyloarthritis
Inflammatory Back Pain
Eligibility:
All Genders
18+ years
Brief Summary
The current ASAS classification of AxSpA relies either on sacroiliitis on imaging plus one SpA feature (imaging arm) or HLA-B27 antigen plus two SpA features (clinical arm), in a patient with chronic ...
Detailed Description
Axial spondyloarthritis (AxSpA) is a chronic inflammatory disease that affects the axial skeleton mainly leading to significant pain and disability. Early diagnosis of AxSpA is important for better ma...
Eligibility Criteria
Inclusion
- Group 1
- Patients diagnosed as AxSpA.
- Age \> 18 years and \< 45 years at onset of the disease. Group 2
- Patients diagnosed as chronic mechanical back pain.
- Age \> 18 years and \< 45 years at onset of the disease.
Exclusion
- Patients having acute or subacute back pain.
- Patients having back pain referred from another site.
- Patients with any other autoimmune disease: rheumatoid arthritis, systemic lupus erythematosus, Behçet's disease… etc.
Key Trial Info
Start Date :
August 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 25 2022
Estimated Enrollment :
206 Patients enrolled
Trial Details
Trial ID
NCT05327140
Start Date
August 20 2021
End Date
May 25 2022
Last Update
January 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zagazig university
Zagazig, Sharqia Province, Egypt